Platelet Dysfunction Due to Drugs Clinical Trial
Official title:
Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Extended Registry
The purpose of this study is to determine the efficacy and safety of a routine individualized
antiplatelet therapy after coronary stent implantation by evaluating "on-treatment" platelet
reactivity with Multiple Electrode Aggregometry (MEA, Multiplate® Analyzer).
IDEAL-PCI Extended is the continuation of the IDEAL-PCI registry with additional focus on
bleeding events and net clinical benefit
Determination of platelet reactivity in patients with percutaneous coronary Intervention as
described in the IDEAL-PCI registry.
In the IDEAL-PCI Extended Registry an additional deescalation arm with reduction of the
standard dual antiplatelet therapy (DAPT) dosis in case of low platelet reactivity to P2Y12
Inhibition or Aspirin with or without bleeding is implemented.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04206176 -
The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT02979158 -
Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass
|
N/A | |
| Withdrawn |
NCT03338660 -
Platelet Function With Various Storage Techniques
|
Phase 2 | |
| Completed |
NCT03603249 -
Trimetazidine as an Adjunct to Enhance Clopidogrel Response.
|
Phase 2 | |
| Completed |
NCT03111420 -
Study of AggreGuide A-100 (ADP) Assay
|
N/A | |
| Recruiting |
NCT03005704 -
Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets
|
N/A | |
| Recruiting |
NCT06228820 -
Aspirin Resistance in Trinidad.
|
Phase 2 | |
| Completed |
NCT04342819 -
The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study.
|
Phase 2/Phase 3 | |
| Completed |
NCT03121898 -
PLATelet Function Operating Room Monitoring
|
||
| Active, not recruiting |
NCT03787927 -
Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets
|
Phase 1/Phase 2 |